{
  "main_header": {
    "sid": 175814,
    "name": "Hikal",
    "stock_name": "Hikal",
    "full_name": "Hikal Ltd",
    "name_url": "stocks-analysis/hikal",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "242.75",
    "chg": -10.2,
    "chgp": "-4.03%",
    "dir": -1,
    "prev_price": "252.95",
    "mcapval": "2,993.13 Cr",
    "mcap": "Small Cap",
    "scripcode": 524735,
    "symbol": "HIKAL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE475B01022",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "27.21 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hikal-175814-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hikal’s Market Assessment Revised Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hikal-downgraded-to-strong-sell-amid-weak-financials-and-negative-trends-3746514",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Hikal_mojoScore_3746514.png",
        "date": "2025-12-04 11:08:06",
        "description": "Hikal, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its market evaluation metrics. This shift reflects a reassessment of the company’s financial health, valuation, and technical outlook amid ongoing operational challenges and market performance trends."
      },
      {
        "title": "Hikal Sees Exceptional Trading Volume Amid Rising Investor Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-sees-exceptional-volume-surge-amid-strong-sell-rating-3746022",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Hikal_most_active_equities_by_volume_3746022.png",
        "date": "2025-12-04 10:00:10",
        "description": "Hikal Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks recently, with a remarkable surge in trading volume and investor participation. The stock's performance has outpaced its sector peers, reflecting heightened market attention and liquidity."
      },
      {
        "title": "Hikal Ltd Sees Elevated Trading Activity Amidst Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-sees-robust-trading-activity-amid-strong-sell-rating-upgrade-3746018",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Hikal_most_active_equities_by_value_3746018.png",
        "date": "2025-12-04 10:00:08",
        "description": "Hikal Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 4 December 2025. The stock demonstrated notable trading volumes and value turnover, alongside a performance that outpaced its sector peers, reflecting heightened investor interest and liquidity in the market."
      },
      {
        "title": "Is Hikal technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-hikal-technically-bullish-or-bearish-3745266",
        "imagepath": "",
        "date": "2025-12-04 08:19:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Technical Trends</strong></p>\n<p>As of 3 December 2025, Hikal’s technical trend has transitioned from a clear bearish stance to a mildly bearish one. This subtle shift indicates that while downward pressure remains, the intensity of the decline has somewhat eased. The stock’s current price stands at ₹243.75, having opened the day with a low of ₹227.40 and reaching a high of ₹254.60, reflecting intraday volatility within a relatively narrow range.</p>\n<p>Examining the 52-week range, Hikal’s shares have traded between ₹217.35 and ₹464.50, highlighting significant depreciation from its peak over the past year. This wide range underscores the challenges the stock has faced amid broader market conditions and sector-specific headwinds.</p>\n<p><strong>Mixed Signals from Key Tech..."
      },
      {
        "title": "Hikal Stock Analysis: Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-shares-show-mixed-technical-signals-amid-price-momentum-shift-3745174",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Hikal_technicaldot_3745174.png",
        "date": "2025-12-04 08:00:56",
        "description": "Hikal, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent price movements and indicator assessments reveal a nuanced market stance as the stock navigates volatility and investor sentiment."
      },
      {
        "title": "Why is Hikal falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hikal-fallingrising-3744927",
        "imagepath": "",
        "date": "2025-12-04 00:40:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Activity</strong></p>\n<p>Hikal’s stock outperformed its sector by 13.02% on the day, trading within a wide range of ₹27.2, signalling heightened volatility and investor interest. The stock’s price currently sits above its 5-day, 20-day, and 50-day moving averages, suggesting short-term bullish momentum. However, it remains below the 100-day and 200-day moving averages, indicating that longer-term trends have yet to turn decisively positive.</p>\n<p>Investor participation has notably increased, with delivery volumes on 02 Dec rising by 24.99% compared to the five-day average, reaching 83.52 lakh shares. This uptick in trading activity points to renewed buying interest, possibly driven by bargain hunting or speculative positioning amid the stock’s recent und..."
      },
      {
        "title": "Hikal Sees Exceptional Trading Volume Amidst Wide Price Range on 3 Dec 2025",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-sees-exceptional-volume-surge-amid-strong-sell-rating-3744368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Hikal_most_active_equities_by_volume_3744368.png",
        "date": "2025-12-03 14:00:06",
        "description": "Hikal Ltd, a key player in the Pharmaceuticals & Biotechnology sector, recorded one of the highest trading volumes on 3 December 2025, with over 2.48 crore shares exchanging hands. The stock exhibited a notable intraday price range, reflecting heightened market activity and investor interest amid a volatile trading session."
      },
      {
        "title": "Hikal Ltd Sees Significant Trading Activity Amidst Sector Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-surges-on-heavy-value-trading-amid-strong-institutional-interest-3744308",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Hikal_most_active_equities_by_value_3744308.png",
        "date": "2025-12-03 13:00:09",
        "description": "Hikal Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, recorded one of the highest value turnovers on 3 December 2025, with trading volumes and price movements that outpaced both its sector and the broader market indices. The stock’s performance on this day highlights a marked divergence from the sector’s subdued returns, reflecting heightened investor interest and liquidity in this small-cap company."
      },
      {
        "title": "Hikal Hits Intraday High with Strong 7.96% Surge Amid Mixed Market Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-hits-intraday-high-with-796-surge-on-3-dec-2025-3743286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Hikal_priceRelatedfactors_3743286.png",
        "date": "2025-12-03 09:32:18",
        "description": "Hikal recorded a robust intraday performance on 3 December 2025, touching a day’s high of Rs 242.65, reflecting a 7.96% gain. This surge notably outpaced the Pharmaceuticals & Biotechnology sector and contrasted with the broader market’s subdued movement."
      }
    ],
    "total": 376,
    "sid": "175814",
    "stock_news_url": "https://www.marketsmojo.com/news/hikal-175814"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "03-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Castilia Life Sciences Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
      "datetime": "03-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Castilia Life Sciences Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "03-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Castilia Life Sciences Pvt Ltd & PACs",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hikal Ltd has declared <strong>40%</strong> dividend, ex-date: 02 Sep 25",
          "dt": "2025-09-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Hikal Ltd has announced <strong>2:10</strong> stock split, ex-date: 27 Feb 15",
          "dt": "2015-02-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hikal Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 18",
          "dt": "2018-06-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Hikal’s Market Assessment Revised Amidst Challenging Financial Trends

2025-12-04 11:08:06

Hikal, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its market evaluation metrics. This shift reflects a reassessment of the company’s financial health, valuation, and technical outlook amid ongoing operational challenges and market performance trends.

Read More

Hikal Sees Exceptional Trading Volume Amid Rising Investor Interest

2025-12-04 10:00:10

Hikal Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks recently, with a remarkable surge in trading volume and investor participation. The stock's performance has outpaced its sector peers, reflecting heightened market attention and liquidity.

Read More

Hikal Ltd Sees Elevated Trading Activity Amidst Sector Outperformance

2025-12-04 10:00:08

Hikal Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 4 December 2025. The stock demonstrated notable trading volumes and value turnover, alongside a performance that outpaced its sector peers, reflecting heightened investor interest and liquidity in the market.

Read More

Is Hikal technically bullish or bearish?

2025-12-04 08:19:25

Overview of Current Technical Trends

As of 3 December 2025, Hikal’s technical trend has transitioned from a clear bearish stance to a mildly bearish one. This subtle shift indicates that while downward pressure remains, the intensity of the decline has somewhat eased. The stock’s current price stands at ₹243.75, having opened the day with a low of ₹227.40 and reaching a high of ₹254.60, reflecting intraday volatility within a relatively narrow range.

Examining the 52-week range, Hikal’s shares have traded between ₹217.35 and ₹464.50, highlighting significant depreciation from its peak over the past year. This wide range underscores the challenges the stock has faced amid broader market conditions and sector-specific headwinds.

Mixed Signals from Key Tech...

Read More

Hikal Stock Analysis: Technical Momentum Shifts Amid Mixed Indicators

2025-12-04 08:00:56

Hikal, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent price movements and indicator assessments reveal a nuanced market stance as the stock navigates volatility and investor sentiment.

Read More

Why is Hikal falling/rising?

2025-12-04 00:40:33

Short-Term Price Movement and Market Activity

Hikal’s stock outperformed its sector by 13.02% on the day, trading within a wide range of ₹27.2, signalling heightened volatility and investor interest. The stock’s price currently sits above its 5-day, 20-day, and 50-day moving averages, suggesting short-term bullish momentum. However, it remains below the 100-day and 200-day moving averages, indicating that longer-term trends have yet to turn decisively positive.

Investor participation has notably increased, with delivery volumes on 02 Dec rising by 24.99% compared to the five-day average, reaching 83.52 lakh shares. This uptick in trading activity points to renewed buying interest, possibly driven by bargain hunting or speculative positioning amid the stock’s recent und...

Read More

Hikal Sees Exceptional Trading Volume Amidst Wide Price Range on 3 Dec 2025

2025-12-03 14:00:06

Hikal Ltd, a key player in the Pharmaceuticals & Biotechnology sector, recorded one of the highest trading volumes on 3 December 2025, with over 2.48 crore shares exchanging hands. The stock exhibited a notable intraday price range, reflecting heightened market activity and investor interest amid a volatile trading session.

Read More

Hikal Ltd Sees Significant Trading Activity Amidst Sector Underperformance

2025-12-03 13:00:09

Hikal Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, recorded one of the highest value turnovers on 3 December 2025, with trading volumes and price movements that outpaced both its sector and the broader market indices. The stock’s performance on this day highlights a marked divergence from the sector’s subdued returns, reflecting heightened investor interest and liquidity in this small-cap company.

Read More

Hikal Hits Intraday High with Strong 7.96% Surge Amid Mixed Market Trends

2025-12-03 09:32:18

Hikal recorded a robust intraday performance on 3 December 2025, touching a day’s high of Rs 242.65, reflecting a 7.96% gain. This surge notably outpaced the Pharmaceuticals & Biotechnology sector and contrasted with the broader market’s subdued movement.

Read More

View All News